721928-03-6 Usage
Description
(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-4-(DIMETHYLAMINO)-4-OXOBUTANOIC ACID is a chemical compound derived from the amino acid glutamic acid. It is characterized by the presence of a tert-butoxycarbonyl (Boc) protecting group on the amino group, which enables selective manipulation of the molecule's reactivity. (R)-2-((TERT-BUTOXYCARBONYL)AMINO)-4-(DIMETHYLAMINO)-4-OXOBUTANOIC ACID is widely utilized in chemical synthesis and serves as a building block for creating peptides and other complex organic molecules.
Uses
Used in Pharmaceutical Industry:
(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-4-(DIMETHYLAMINO)-4-OXOBUTANOIC ACID is used as a reagent for the synthesis of peptides and other bioactive molecules, contributing to the development of new drugs and therapies.
Used in Organic Chemistry Research:
(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-4-(DIMETHYLAMINO)-4-OXOBUTANOIC ACID is used as an important tool in organic chemistry research, facilitating the study and understanding of complex molecular structures and reactions.
Used in Drug Development:
(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-4-(DIMETHYLAMINO)-4-OXOBUTANOIC ACID is employed in drug development as a key component in the design and synthesis of novel pharmaceutical compounds, potentially leading to the creation of new treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 721928-03-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,1,9,2 and 8 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 721928-03:
(8*7)+(7*2)+(6*1)+(5*9)+(4*2)+(3*8)+(2*0)+(1*3)=156
156 % 10 = 6
So 721928-03-6 is a valid CAS Registry Number.
721928-03-6Relevant articles and documents
NOVEL ETHYLENEDIAMINE DERIVATIVES
-
Page/Page column 229, (2010/02/14)
A compound represented by the following formula (1):Q-Q-T-N(R)-Q-N(R)-T-Q [wherein, R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6- membered cyclic hydrocarbon group which may have a substituent, or the like; Q2 is a single bond or the like; Q3 represents the following group: -C(R3a)(R4a)-{C(R3b)(R4b)}m1-{C(R3c)(R4c)}m2-{C(R3d)(R4d)}m3-{C(R3e)(R4e)}m4-C(R3f)(R4f)- (in which, R3a to R4e represent hydrogen or the like); T0 represents a carbonyl group or the like; and T1 represents -COCONR- or the like]; or salt thereof, solvate thereof, or N-oxide thereof. The compound is useful as a preventive and/or therapeutic agent for cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
